{"transactions":[{"id":706963,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":false,"shares":5125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":24011,"derivative":{"exercise_price":7.96,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":5125},"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706962,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":false,"shares":16048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.19,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16048},"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706961,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":false,"shares":7606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":20.56,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":7606},"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706960,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":100,"price":36.55,"value":3655.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."}],"balance_after":36686,"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706959,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":28679,"price":36.1445,"value":1036588.1155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.55 to $36.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36786,"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706958,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":true,"shares":5125,"price":7.96,"value":40795.0,"ownership":{"direct":true},"balance_after":65465,"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706957,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":true,"shares":16048,"price":14.19,"value":227721.12,"ownership":{"direct":true},"balance_after":60340,"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":706956,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:22:50.000Z","date":"2026-07-16","kind":"exercise","planned":true,"acquired":true,"shares":7606,"price":20.56,"value":156379.36,"ownership":{"direct":true},"balance_after":44292,"source":{"system":"sec-edgar","filing":"0001855608-26-000004","document":"form4-07172026_080746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000004/form4-07172026_080746.xml","form_type":"4"}},{"id":727802,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:06:22.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":2808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":5617,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":2808},"source":{"system":"sec-edgar","filing":"0001470831-26-000635","document":"wk-form4_1782338780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000635/wk-form4_1782338780.xml","form_type":"4"}},{"id":727801,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:06:22.000Z","date":"2026-06-22","kind":"grant","planned":true,"acquired":true,"shares":5277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."}],"balance_after":5277,"derivative":{"exercise_price":68.92,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":5277},"source":{"system":"sec-edgar","filing":"0001470831-26-000635","document":"wk-form4_1782338780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000635/wk-form4_1782338780.xml","form_type":"4"}},{"id":727800,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:22.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":2196,"price":68.57,"value":150579.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025."}],"balance_after":9259,"source":{"system":"sec-edgar","filing":"0001470831-26-000635","document":"wk-form4_1782338780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000635/wk-form4_1782338780.xml","form_type":"4"}},{"id":727799,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:22.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":2808,"price":68,"value":190944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025."}],"balance_after":11455,"source":{"system":"sec-edgar","filing":"0001470831-26-000635","document":"wk-form4_1782338780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000635/wk-form4_1782338780.xml","form_type":"4"}},{"id":727798,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:22.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":2808,"price":41.73,"value":117177.84,"ownership":{"direct":true},"balance_after":14263,"source":{"system":"sec-edgar","filing":"0001470831-26-000635","document":"wk-form4_1782338780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000635/wk-form4_1782338780.xml","form_type":"4"}},{"id":727797,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:22.000Z","date":"2026-06-22","kind":"grant","planned":true,"acquired":true,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":11455,"source":{"system":"sec-edgar","filing":"0001470831-26-000635","document":"wk-form4_1782338780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000635/wk-form4_1782338780.xml","form_type":"4"}},{"id":736373,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:51:28.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":12103,"price":23.1123,"value":279728.1669,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36686,"source":{"system":"sec-edgar","filing":"0001855608-26-000003","document":"form4-06162026_090624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000003/form4-06162026_090624.xml","form_type":"4"}},{"id":736372,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:51:28.000Z","date":"2026-06-12","kind":"grant","planned":true,"acquired":true,"shares":9795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date."}],"balance_after":48789,"source":{"system":"sec-edgar","filing":"0001855608-26-000003","document":"form4-06162026_090624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000185560826000003/form4-06162026_090624.xml","form_type":"4"}},{"id":749741,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:24:34.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":223492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":223492,"derivative":{"exercise_price":1.58,"exercise_date":"2026-07-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":223492},"source":{"system":"sec-edgar","filing":"0001299130-26-000102","document":"wk-form4_1780608272.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913026000102/wk-form4_1780608272.xml","form_type":"4"}},{"id":846375,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-12T20:15:36.000Z","date":"2026-03-10","kind":"exercise","planned":true,"acquired":false,"shares":8671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":17343,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":8671},"source":{"system":"sec-edgar","filing":"0001470831-26-000260","document":"wk-form4_1773346534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000260/wk-form4_1773346534.xml","form_type":"4"}},{"id":846374,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:15:36.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":8671,"price":72,"value":624312.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025."}],"balance_after":7465,"source":{"system":"sec-edgar","filing":"0001470831-26-000260","document":"wk-form4_1773346534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000260/wk-form4_1773346534.xml","form_type":"4"}},{"id":846373,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:15:36.000Z","date":"2026-03-10","kind":"exercise","planned":true,"acquired":true,"shares":8671,"price":27.36,"value":237238.56,"ownership":{"direct":true},"balance_after":16136,"source":{"system":"sec-edgar","filing":"0001470831-26-000260","document":"wk-form4_1773346534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000260/wk-form4_1773346534.xml","form_type":"4"}},{"id":868121,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:17:15.000Z","date":"2026-02-27","kind":"exercise","planned":true,"acquired":false,"shares":25484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable in three annual installments after October 25, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":0,"derivative":{"exercise_price":48.45,"expiration_date":"2031-10-24","underlying":"Common Stock","underlying_shares":25484},"source":{"system":"sec-edgar","filing":"0001470831-26-000236","document":"wk-form4_1772572630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000236/wk-form4_1772572630.xml","form_type":"4"}},{"id":868120,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T21:17:15.000Z","date":"2026-02-27","kind":"sale","planned":true,"acquired":false,"shares":10900,"price":67.8437,"value":739496.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $67.42 to $68.31 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":7465,"source":{"system":"sec-edgar","filing":"0001470831-26-000236","document":"wk-form4_1772572630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000236/wk-form4_1772572630.xml","form_type":"4"}},{"id":868119,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T21:17:15.000Z","date":"2026-02-27","kind":"sale","planned":true,"acquired":false,"shares":14584,"price":67.0793,"value":978284.5112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $66.42 to $67.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":18365,"source":{"system":"sec-edgar","filing":"0001470831-26-000236","document":"wk-form4_1772572630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000236/wk-form4_1772572630.xml","form_type":"4"}},{"id":868118,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T21:17:15.000Z","date":"2026-02-27","kind":"exercise","planned":true,"acquired":true,"shares":25484,"price":48.45,"value":1234699.8,"ownership":{"direct":true},"balance_after":32949,"source":{"system":"sec-edgar","filing":"0001470831-26-000236","document":"wk-form4_1772572630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083126000236/wk-form4_1772572630.xml","form_type":"4"}},{"id":998976,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-14T21:50:41.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":25484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and became exercisable in three annual installments after October 25, 2021."}],"balance_after":25484,"derivative":{"exercise_price":48.45,"expiration_date":"2031-10-24","underlying":"Common Stock","underlying_shares":25484},"source":{"system":"sec-edgar","filing":"0001470831-25-000317","document":"wk-form4_1763157038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083125000317/wk-form4_1763157038.xml","form_type":"4"}},{"id":998975,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:50:41.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":25484,"price":66.07,"value":1683727.88,"ownership":{"direct":true},"balance_after":7465,"source":{"system":"sec-edgar","filing":"0001470831-25-000317","document":"wk-form4_1763157038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083125000317/wk-form4_1763157038.xml","form_type":"4"}},{"id":998974,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:50:41.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":25484,"price":48.45,"value":1234699.8,"ownership":{"direct":true},"balance_after":32949,"source":{"system":"sec-edgar","filing":"0001470831-25-000317","document":"wk-form4_1763157038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000147083125000317/wk-form4_1763157038.xml","form_type":"4"}},{"id":1099368,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:51:41.000Z","date":"2025-06-26","kind":"sale","planned":false,"acquired":false,"shares":1891,"price":44.0303,"value":83261.2973,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":398,"source":{"system":"sec-edgar","filing":"0000950170-25-091762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091762/ownership.xml","form_type":"4"}},{"id":1099367,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:51:41.000Z","date":"2025-06-26","kind":"sale","planned":false,"acquired":false,"shares":398,"price":44.1263,"value":17562.2674,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $44.12 to $44.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":2289,"source":{"system":"sec-edgar","filing":"0000950170-25-091762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091762/ownership.xml","form_type":"4"}},{"id":1099366,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:51:41.000Z","date":"2025-06-26","kind":"sale","planned":false,"acquired":false,"shares":1542,"price":44.01,"value":67863.42,"ownership":{"direct":true},"balance_after":7465,"source":{"system":"sec-edgar","filing":"0000950170-25-091762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091762/ownership.xml","form_type":"4"}},{"id":1099365,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:51:41.000Z","date":"2025-06-26","kind":"sale","planned":false,"acquired":false,"shares":876,"price":44.1099,"value":38640.2724,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $44.025 to $44.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":9007,"source":{"system":"sec-edgar","filing":"0000950170-25-091762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091762/ownership.xml","form_type":"4"}},{"id":1099364,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:49:25.000Z","date":"2021-12-29","kind":"purchase","planned":false,"acquired":true,"shares":1752,"price":14.24,"value":24948.48,"ownership":{"direct":true},"balance_after":3294,"source":{"system":"sec-edgar","filing":"0000950170-25-091759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091759/ownership.xml","form_type":"4/A","original_submission_date":"2022-01-03"}},{"id":1099363,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:46:18.000Z","date":"2021-12-28","kind":"purchase","planned":false,"acquired":true,"shares":796,"price":13.16,"value":10475.36,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":2687,"source":{"system":"sec-edgar","filing":"0000950170-25-091756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091756/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-13"}},{"id":1099362,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:46:18.000Z","date":"2021-12-28","kind":"purchase","planned":false,"acquired":true,"shares":1542,"price":12.68,"value":19552.56,"ownership":{"direct":true},"balance_after":1542,"source":{"system":"sec-edgar","filing":"0000950170-25-091756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025091756/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-13"}},{"id":1102747,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:55:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":8425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":8425,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":8425},"source":{"system":"sec-edgar","filing":"0000950170-25-089643","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025089643/ownership.xml","form_type":"4"}},{"id":1102746,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:55:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":6589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":8353,"source":{"system":"sec-edgar","filing":"0000950170-25-089643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025089643/ownership.xml","form_type":"4"}},{"id":1103930,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T20:30:05.000Z","date":"2025-06-18","kind":"sale","planned":true,"acquired":false,"shares":10570,"price":19.1642,"value":202565.594,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.62, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4"}],"balance_after":38994,"source":{"system":"sec-edgar","filing":"0000950170-25-089022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025089022/ownership.xml","form_type":"4"}},{"id":1108163,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T20:30:16.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":12103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest in one installment on earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025."}],"balance_after":49564,"source":{"system":"sec-edgar","filing":"0000950170-25-087412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025087412/ownership.xml","form_type":"4"}},{"id":1115169,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-06-11T21:00:04.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":false,"shares":4292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":34334,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":4292},"source":{"system":"sec-edgar","filing":"0000950170-25-084914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025084914/ownership.xml","form_type":"4"}},{"id":1115168,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T21:00:04.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":4292,"price":40,"value":171680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":1764,"source":{"system":"sec-edgar","filing":"0000950170-25-084914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025084914/ownership.xml","form_type":"4"}},{"id":1115167,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T21:00:04.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":true,"shares":4292,"price":16.75,"value":71891.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":6056,"source":{"system":"sec-edgar","filing":"0000950170-25-084914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025084914/ownership.xml","form_type":"4"}},{"id":1119896,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:06:41.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":65000,"derivative":{"exercise_price":1.03,"exercise_date":"2025-07-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001299130-25-000132","document":"wk-form4_1749240394.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913025000132/wk-form4_1749240394.xml","form_type":"4"}},{"id":1215227,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-03-10T20:43:50.000Z","date":"2025-03-06","kind":"exercise","planned":true,"acquired":false,"shares":12875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three annual installments starting on June 21, 2024 and ending on June 21, 2026, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":38626,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":12875},"source":{"system":"sec-edgar","filing":"0000950170-25-036420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025036420/ownership.xml","form_type":"4"}},{"id":1215226,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-10T20:43:50.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":12875,"price":32.5825,"value":419499.6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $32.17 to $33.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":1764,"source":{"system":"sec-edgar","filing":"0000950170-25-036420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025036420/ownership.xml","form_type":"4"}},{"id":1215225,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-10T20:43:50.000Z","date":"2025-03-06","kind":"exercise","planned":true,"acquired":true,"shares":12875,"price":16.75,"value":215656.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":14639,"source":{"system":"sec-edgar","filing":"0000950170-25-036420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017025036420/ownership.xml","form_type":"4"}},{"id":1469638,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:42:38.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":26014,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":26014},"source":{"system":"sec-edgar","filing":"0000950170-24-077455","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024077455/ownership.xml","form_type":"4"}},{"id":1473370,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T00:54:00.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":16048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price of the derivative security of the Stock Option (right to buy) reported on the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025."}],"balance_after":16048,"derivative":{"exercise_price":14.19,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":16048},"source":{"system":"sec-edgar","filing":"0000950170-24-075819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024075819/ownership.xml","form_type":"4/A","original_submission_date":"2024-06-18"}},{"id":1473369,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T21:04:39.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":32179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":32179,"derivative":{"exercise_price":1.65,"exercise_date":"2024-07-18","expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":32179},"source":{"system":"sec-edgar","filing":"0001299130-24-000156","document":"wk-form4_1718917472.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913024000156/wk-form4_1718917472.xml","form_type":"4"}},{"id":1473368,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T21:04:39.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":22821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest on the one (1) year anniversary of the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":22821,"source":{"system":"sec-edgar","filing":"0001299130-24-000156","document":"wk-form4_1718917472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913024000156/wk-form4_1718917472.xml","form_type":"4"}},{"id":1475593,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:43:00.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":16048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025."}],"balance_after":16048,"derivative":{"exercise_price":9.3469,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":16048},"source":{"system":"sec-edgar","filing":"0000950170-24-074950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024074950/ownership.xml","form_type":"4"}},{"id":1475592,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:43:00.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":10570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest in one installment on June 14, 2025."}],"balance_after":37461,"source":{"system":"sec-edgar","filing":"0000950170-24-074950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024074950/ownership.xml","form_type":"4"}},{"id":1634174,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-02-20T21:03:00.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":false,"shares":2915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying the option vested on June 22, 2023; thereafter, 1/3rd of the underlying shares vest on an annual basis, so that all of the underlying shares will be vested on June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":93261,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":2915},"source":{"system":"sec-edgar","filing":"0000950170-24-017081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024017081/ownership.xml","form_type":"4"}},{"id":1634173,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T21:03:00.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":2915,"price":37.75,"value":110041.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":1764,"source":{"system":"sec-edgar","filing":"0000950170-24-017081","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024017081/ownership.xml","form_type":"4"}},{"id":1634172,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T21:03:00.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":true,"shares":2915,"price":8.45,"value":24631.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":4679,"source":{"system":"sec-edgar","filing":"0000950170-24-017081","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024017081/ownership.xml","form_type":"4"}},{"id":1646516,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-13T21:05:15.000Z","date":"2021-12-28","kind":"purchase","planned":false,"acquired":true,"shares":1542,"price":12.68,"value":19552.56,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3433,"source":{"system":"sec-edgar","filing":"0000950170-24-014537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024014537/ownership.xml","form_type":"5"}},{"id":1646515,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-13T21:05:15.000Z","date":"2021-12-28","kind":"purchase","planned":false,"acquired":true,"shares":1891,"price":13.18,"value":24923.38,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1891,"source":{"system":"sec-edgar","filing":"0000950170-24-014537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024014537/ownership.xml","form_type":"5"}},{"id":1646510,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-13T21:00:10.000Z","date":"2021-12-28","kind":"purchase","planned":false,"acquired":true,"shares":1542,"price":12.68,"value":19552.56,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3433,"source":{"system":"sec-edgar","filing":"0000950170-24-014523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024014523/ownership.xml","form_type":"4"}},{"id":1646509,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-13T21:00:10.000Z","date":"2021-12-28","kind":"purchase","planned":false,"acquired":true,"shares":1891,"price":13.18,"value":24923.38,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1891,"source":{"system":"sec-edgar","filing":"0000950170-24-014523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024014523/ownership.xml","form_type":"4"}},{"id":1676563,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-18T21:10:54.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":false,"shares":2915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying the option vested on June 22, 2023; thereafter, 1/3rd of the underlying shares vest on an annual basis, so that all of the underlying shares will be vested on June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":96176,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":2915},"source":{"system":"sec-edgar","filing":"0000950170-24-005380","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024005380/ownership.xml","form_type":"4"}},{"id":1676562,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-18T21:10:54.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":2915,"price":37.97,"value":110682.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":1764,"source":{"system":"sec-edgar","filing":"0000950170-24-005380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024005380/ownership.xml","form_type":"4"}},{"id":1676561,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-18T21:10:54.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":true,"shares":2915,"price":8.45,"value":24631.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":4679,"source":{"system":"sec-edgar","filing":"0000950170-24-005380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000095017024005380/ownership.xml","form_type":"4"}},{"id":1705110,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-19T21:00:06.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":false,"shares":2915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":99091,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":2915},"source":{"system":"sec-edgar","filing":"0001209191-23-059101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123059101/doc4.xml","form_type":"4"}},{"id":1705109,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T21:00:06.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":2915,"price":36.12,"value":105289.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":1764,"source":{"system":"sec-edgar","filing":"0001209191-23-059101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123059101/doc4.xml","form_type":"4"}},{"id":1705108,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T21:00:06.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":true,"shares":2915,"price":8.45,"value":24631.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":4679,"source":{"system":"sec-edgar","filing":"0001209191-23-059101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123059101/doc4.xml","form_type":"4"}},{"id":1737006,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-17T21:09:47.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":false,"shares":2915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":102006,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":2915},"source":{"system":"sec-edgar","filing":"0001209191-23-055717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123055717/doc4.xml","form_type":"4"}},{"id":1737005,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T21:09:47.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":2915,"price":30,"value":87450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":1764,"source":{"system":"sec-edgar","filing":"0001209191-23-055717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123055717/doc4.xml","form_type":"4"}},{"id":1737004,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T21:09:47.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":true,"shares":2915,"price":8.45,"value":24631.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 16, 2023."}],"balance_after":4679,"source":{"system":"sec-edgar","filing":"0001209191-23-055717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123055717/doc4.xml","form_type":"4"}},{"id":1845413,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:25:27.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":51501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":51501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":51501},"source":{"system":"sec-edgar","filing":"0001209191-23-039396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919123039396/doc4.xml","form_type":"4"}},{"id":1848004,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:52:41.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":29136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 16, 2023 and the shares subject to the option shall vest monthly thereafter through June 16, 2024."}],"balance_after":29136,"derivative":{"exercise_price":7.96,"expiration_date":"2033-06-16","underlying":"Common Stock","underlying_shares":29136},"source":{"system":"sec-edgar","filing":"0001217234-23-000131","document":"wf-form4_168738794512801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723423000131/wf-form4_168738794512801.xml","form_type":"4"}},{"id":1848003,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:52:41.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":18844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 16, 2024."}],"balance_after":26891,"source":{"system":"sec-edgar","filing":"0001217234-23-000131","document":"wf-form4_168738794512801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723423000131/wf-form4_168738794512801.xml","form_type":"4"}},{"id":1876728,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-26T20:56:23.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":25775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":25775,"derivative":{"exercise_price":11.94,"exercise_date":"2023-06-24","expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":25775},"source":{"system":"sec-edgar","filing":"0001299130-23-000082","document":"wf-form4_168513453246545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913023000082/wf-form4_168513453246545.xml","form_type":"4"}},{"id":2059033,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T22:26:47.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":8047,"source":{"system":"sec-edgar","filing":"0001217234-23-000008","document":"wf-form4_167330319267954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723423000008/wf-form4_167330319267954.xml","form_type":"4"}},{"id":2145013,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T21:40:52.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":7371,"source":{"system":"sec-edgar","filing":"0001217234-22-000174","document":"wf-form4_166491963378065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723422000174/wf-form4_166491963378065.xml","form_type":"4"}},{"id":2212232,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T20:36:51.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":6949,"source":{"system":"sec-edgar","filing":"0001217234-22-000139","document":"wf-form4_165713979220037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723422000139/wf-form4_165713979220037.xml","form_type":"4"}},{"id":2222193,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:38:42.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000120919122039270/doc4.xml","form_type":"4"}},{"id":2225697,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:09:28.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":7606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option shall vest on July 16, 2022 and the shares subject to the option shall vest monthly thereafter through June 16, 2023."}],"balance_after":7606,"derivative":{"exercise_price":20.56,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":7606},"source":{"system":"sec-edgar","filing":"0001217234-22-000123","document":"wf-form4_165584574785603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723422000123/wf-form4_165584574785603.xml","form_type":"4"}},{"id":2225696,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T21:09:28.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":4863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units which shall vest on June 16, 2023."}],"balance_after":6624,"source":{"system":"sec-edgar","filing":"0001217234-22-000123","document":"wf-form4_165584574785603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723422000123/wf-form4_165584574785603.xml","form_type":"4"}},{"id":2253738,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T23:35:16.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":63015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":63015,"derivative":{"exercise_price":5.37,"exercise_date":"2022-06-25","expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":63015},"source":{"system":"sec-edgar","filing":"0001299130-22-000087","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913022000087/certent-form4.xml","form_type":"4"}},{"id":2454556,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T00:53:03.000Z","date":"2021-12-29","kind":"purchase","acquired":true,"shares":1764,"price":14.23,"value":25101.72,"ownership":{"direct":true},"balance_after":1764,"source":{"system":"sec-edgar","filing":"0000899243-22-000180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000089924322000180/doc4.xml","form_type":"4"}},{"id":2534698,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-27T01:16:49.000Z","date":"2021-10-25","kind":"grant","acquired":true,"shares":50968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after October 25, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":50968,"derivative":{"exercise_price":48.45,"expiration_date":"2031-10-24","underlying":"Common Stock","underlying_shares":50968},"source":{"system":"sec-edgar","filing":"0000899243-21-041672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000089924321041672/doc4.xml","form_type":"4"}},{"id":2552379,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:43:33.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":1761,"source":{"system":"sec-edgar","filing":"0001217234-21-000221","document":"wf-form4_163338019526676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723421000221/wf-form4_163338019526676.xml","form_type":"4"}},{"id":2645304,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-02T23:28:07.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":1630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/36th of the shares subject to the option shall vest on August 1, 2021 and 1/36th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":1630,"derivative":{"exercise_price":91.99,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":1630},"source":{"system":"sec-edgar","filing":"0001217234-21-000160","document":"wf-form4_162526846819039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723421000160/wf-form4_162526846819039.xml","form_type":"4"}},{"id":2645303,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T23:28:07.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":1630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units 1/3rd of which shall vest on July 1, 2022 and 1/3rd of which shall vest on each anniversary thereafter."}],"balance_after":1630,"source":{"system":"sec-edgar","filing":"0001217234-21-000160","document":"wf-form4_162526846819039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000121723421000160/wf-form4_162526846819039.xml","form_type":"4"}},{"id":2661532,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":29779,"kind":"person","name":"Valantine Hannah","position":1,"cik":"0001855608","reported_name":"Valantine Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T01:46:15.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":28992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Dr. Valantine was elected to the Board of Directors on June 16, 2021.  One-third of the shares subject to the option will vest on the one year anniversary of Dr. Valantine joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as her initial start date, provided she continues to serve as a director through each vesting date."}],"balance_after":28992,"derivative":{"exercise_price":27.9,"exercise_date":"2022-06-16","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":28992},"source":{"system":"sec-edgar","filing":"0001299130-21-000186","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855608/000129913021000186/certent-form4.xml","form_type":"4"}}]}